China Supplier (R)-1 2 3 4-Tetrahedro-naphthoic acid - Methyl 4-(Bromomethyl)-3-Methoxybenzoate CAS 70264-94-7 Zafirlukast Intermediate – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
China Supplier (R)-1 2 3 4-Tetrahedro-naphthoic acid - Methyl 4-(Bromomethyl)-3-Methoxybenzoate CAS 70264-94-7 Zafirlukast Intermediate – Ruifu Detail:

Manufacturer Supply, High Purity, Commercial Production 
Chemical Name: Methyl 4-(Bromomethyl)-3-Methoxybenzoate 
CAS: 70264-94-7

Chemical Name Methyl 4-(Bromomethyl)-3-Methoxybenzoate
Synonyms 4-(Bromomethyl)-3-methoxybenzoic Acid Methyl Ester; Methyl 4-(Bromomethyl)-m-anisate; 4-(Bromomethyl)-m-anisic Acid Methyl Ester 
CAS Number 70264-94-7
CAT Number RF-PI437
Stock Status In Stock 
Molecular Formula C10H11BrO3
Molecular Weight 259.10 
Melting Point 92.0 to 94.0℃
Density  1.432
Brand Ruifu Chemical
Item Specifications
Appearance Pale Yellow Powder
Assay / Analysis Method ≥98.0% (HPLC)
Loss on Drying ≤1.0%
Residue on Ignition ≤0.50%
Total Impurities ≤2.0%
Heavy Metals ≤20ppm
Test Standard Enterprise Standard
Usage Intermediate of Zafirlukast (CAS: 107753-78-6), Used as an antiasthmatic

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

1

Methyl 4-(Bromomethyl)-3-Methoxybenzoate (CAS 70264-94-7) is used as an intermediate of Zafirlukast (CAS: 107753-78-6). Zafirlukast is a highly selective and long-acting oral lys-LTs antagonist. Leukotrienes play an important role in the pathogenesis of asthma. These substances are peptides, being capable of selectively binding to LTC4, LTD4 and LTE4 receptor for antagonism of its effect, reducing the symptoms of asthma and improving lung function. This product is both a preventive agent of inflammation caused by asthma (being antagonistic to leukotriene proinflammatory activity) and a relief drug for bronchial asthma (be antagonistic to leukotriene induced bronchial smooth muscle contraction). The use of this product does not change the smooth muscle response to β2 receptors and has good efficacy in the treatment of bronchoconstriction caused by antigen, aspirin, exercise and cold air, being able to reduce the dosage of hormone and β2 receptor agonist.


Product detail pictures:

China Supplier (R)-1 2 3 4-Tetrahedro-naphthoic acid - Methyl 4-(Bromomethyl)-3-Methoxybenzoate CAS 70264-94-7 Zafirlukast Intermediate – Ruifu detail pictures


Related Product Guide:

China Supplier (R)-1 2 3 4-Tetrahedro-naphthoic acid - Methyl 4-(Bromomethyl)-3-Methoxybenzoate CAS 70264-94-7 Zafirlukast Intermediate – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us